Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

MHRA

- PMLiVE

Steve Arnold joins UCB from Gilead

Appointed managing director for the British and Irish Isles

- PMLiVE

Medical researcher jailed for faking trial data

MHRA completes first prosecution under Good Laboratory Practice Regulations

- PMLiVE

MHRA launches virtual ‘innovation office’

Aims to smooth regulatory pathway for companies developing novel medicines, devices or technology

- PMLiVE

UCB CEO: Patient info more important than transparency

Roch Doliveux says misinformation is the “worst thing that can happen in healthcare”

- PMLiVE

UCB says new medicines drive growth in 2012

Also optimistic about its late-stage pipeline

- PMLiVE

UCB signs research deal for novel neuroscience drugs

Partners with structural biology company ConfometRx

- PMLiVE

UCB-Amgen pull development of drug to heal fractures

But romosozumab remains on course in postmenopausal osteoporosis

- PMLiVE

Increase in unlicensed medicines sold in UK

MHRA says drugs from Eastern Europe finding their way to UK stores

- PMLiVE

MHRA campaign to revive GP, pharmacist and public reporting of side effects

Medicines watchdog to drive awareness of Yellow Card System

- PMLiVE

MHRA plays catch up with pharma on Twitter

UK regulator launches corporate account on the social network

UCB launches arthritis exercise programme in the UK

Scheme was piloted at two NHS Trusts during 2011

- PMLiVE

Eliquis and Ryzodeg feature among Japan’s year-end approvals

Actonel and Neupro also given green light

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links